Fogorvosi szemle, 2018 (111. évfolyam, 1-4. szám)
2018-03-01 / 1. szám
23 FOGORVOSI SZEMLE ■ 111. évf. 1. sz. 2018. la, India: a cluster-randomised controlled trial. Lancet. 2005; 365: 1927-1933. 73. Sankaranarayanan R, Ramadas K, Thara R, Muwonge R, Thomas G, Anju G et al: Long term effect of visual screening on oral cancer incidence and mortality in a randomized trial in Kerala, India. Oral Oncol. 2013; 49: 314-321. 74. Sebestyén A, Boncz I, Dózsa Cs, Pál M, Bánóczy J: Fogászati preventív vizsgálatok Magyarországon. IME. 2003. S3:15-21. 75. Seoane Lestón J, Diz Dios P: Diagnostic clinical aids in oral cancer. Oral Oncol. 2010; 46: 418-422. 76. Shapiro S, Venet W, Strax P, Venet L, Roeser R: Selection, follow-up and analysis in the Health Insurrance Plan study: a randomised trial with breast cancer screening. Natl Cancer Inst Monographys. 1985; 67: 65-74. 77. Singhi AD, Westra WH: Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer. 2010; 116: 2166-2173. 78. Silverman S Jr: Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. J Am Dent Assoc. 2001; 132(Suppl 1): 7S-11S. 79. Shin D, Vigneswaran N, Gillenwater A, Richards-Kortum R: Advances in fluorescence imaging techniques to detect oral cancer and its precursors. Future Oncol. 2010; 6: 1143-1154. 80. Smith EM, Ritchie JM, Summersgill KF, Klussmann JP, Lee JH, Wang D et al: Age, sexual behaviour, and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer. 2004. 108: 766-772. 81. Sonkodi I, Tóth K: Újabb adatok szegedi ipari munkások stomatoonkologiai vizsgálatáról. Népegészségügy. 1975; 56: 282-284. 82. Speight TM, Palmer S, Moles DR, Downer MC, Smith DH, Henriksson M et al: The cost-effectiveness os screening for pral cancer in primary care. Health Technoi Asses. 2006; 10: 1-144. 83. Speight PM, Warnakulasuriya S: Evaluation of screening for oral cancer against National Screening Committee Criteria. UK National Screening Committee Publications. 2010. Available from: http://www. screening.nhs.uk/oralcancer. 84. Smith RA, Cokkinides V, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D et al: Cancer screening in the United States, 2011 : A review of current American Cancer Society (ACS) guidelines and issues in cancer screening. CA Cancer J Clin. 2011 ; 61: 8-30. 85. Steele TO, Meyers, A: Early detection of premalignant lesions and oral cancer. Otolaryngol Clin North Am. 2011 ; 44: 221- 229. 86. Stewart BV, Christopher PW (eds): World Cancer Report 2014. IARC-Lyon. 2014. 87. Szabó Gy, Klenk G: A krónikus alkoholfogyasztás és a dohányzás összegfüggése a szájüregi rákbetegséggel (szűrővizsgálat veszélyeztetett populációban). Orv Hetit. 1997; 138: 3297- 3299. 88. Tabár L, Fagenberg G, Gad A, Baldetorp L, Holmberg LH, Gröntoft O et al: Reduction in mortality from breast cancer after mass screening with mammography. Randomized trial from the Breast Cancer Screening Workomg Group of the Swedish National Board of Health and Welfare. Lancet. 1985; i: 829-832. 89. Tomatis L (ed): Cancer: causes, occurance and control. IARC. Sei Publ. No.100. IARC Lyon. 1990. 90. Tuyn AJ, Esteve J, Raymond I, Berrino F, Benhamou E, Blanchet F et al: Cancer of larynx/hypopharynx, tocacco and alcohol. IARC international case-control study in Turin and Varese (Italy), Zaragosa and Novarra (Spain), Geneve (Switzerland) and Calvados (France). Int J Cancer. 1988; 41: 489-491. 91. Van Der Waal I, De Bree R, Brakenhoff R: Early diagnosis in primary oral cancer: is it possible? Med Oral Patol Oral Cir Bucal. 2011; 16: 300-305. 92. Vokó Z, Túri G, Zsólyom A: Szájüregi szűrés költség-hatékonysága Magyarországon. Orv Hetit. 2016; 157: 1161-1170. 93. Walsh MM, Rankin KV, Silverman S Jr: Influence of continuing education on dental hygienists’ knowledge and behavior related to oral cancer screening and tobacco cessation. J Dent Hyg. 2013.87:95-105. 94. Warnakulasuriya S, Johnson NW, Van der Waal I: Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007; 36: 575-580. 95. Warnakulasuriya S: Significant oral cancer risk associated with low socioeconomic status. Evid Based Dent. 2009; 10: 4-5. 96. Warnakulasuriya S: Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009; 45: 309-316. 97. WHO Collaborating Centre for oral precancerous lesions. Definition of leukoplakia and related lesions. Oral Surg Oral Med Oral Pathol. 1974; 46: 518-529. 98. Zheng, T, Boyle P: Tobacco use and risk of oral cancer. In: Boyle P, Gray N, Henningfield J, Seffrin J and Zatonski W (eds). Tobacco: Science, Policy and Public Health Döbrőssy L, Budai A Epidemiology of oral cancers and the importance of their early detection. Oral screening 2018 In Hungary, the incidence of oral cancer and the mortality of oral cancer patients are so high, that in the past decades it has attracted international attention. The mortality rates are the highest in Europe. As risk factors, smoking and alcohol consumption have a multiplicative role; in addition, a number of dental factors also play a role. Premalignant conditions and lesions are well known. They should be targeted for early detection and early treatment. The screening tool is simple: inspection and palpation. The physician-patient encounters provide opportunity for screening. This paper looks for the answer to the long been debated question: who is responsible for oral screening? Keywords: oral cancer, premalignant lesions, early detection by screening
